These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8522210)

  • 1. [Contemporary views on use of estrogen replacement therapy in postmenopausal women. I. Hormone therapy in women with menopausal osteoporosis].
    Krasomski G
    Ginekol Pol; 1995 Jan; 66(1):28-31. PubMed ID: 8522210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.
    Lindsay R; Nieves J; Formica C; Henneman E; Woelfert L; Shen V; Dempster D; Cosman F
    Lancet; 1997 Aug; 350(9077):550-5. PubMed ID: 9284777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis prevention with sex hormone replacement therapy.
    Rozenberg S; Vandromme J; Kroll M; Pastijn A; Degueldre M
    Int J Fertil Menopausal Stud; 1994; 39(5):262-71. PubMed ID: 7820159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of exercise training on bone remodeling, insulin-like growth factors, and bone mineral density in postmenopausal women with and without hormone replacement therapy.
    Milliken LA; Going SB; Houtkooper LB; Flint-Wagner HG; Figueroa A; Metcalfe LL; Blew RM; Sharp SC; Lohman TG
    Calcif Tissue Int; 2003 Apr; 72(4):478-84. PubMed ID: 12574871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and evolving approaches to individualizing estrogen receptor-based therapy for menopausal women.
    Santen RJ; Kagan R; Altomare CJ; Komm B; Mirkin S; Taylor HS
    J Clin Endocrinol Metab; 2014 Mar; 99(3):733-47. PubMed ID: 24423357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations on the management of fragility fracture risk in women younger than 70 years.
    Palacios S; Christiansen C; Sánchez Borrego R; Gambacciani M; Hadji P; Karsdal M; Lambrinoudaki I; Lello S; O'Beirne B; Romao F; Rozenberg S; Stevenson JC; Ben-Rafael Z
    Gynecol Endocrinol; 2012 Oct; 28(10):770-86. PubMed ID: 22558997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis: new hope for the future.
    Masi L; Bilezikian JP
    Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy in postmenopausal women.
    Prelevic GM; Kocjan T; Markou A
    Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substitutive hormonal treatment in postmenopause.
    Gangemi M; De Candia O; De Candia R
    Clin Exp Obstet Gynecol; 1995; 22(2):143-4. PubMed ID: 7781181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmenopausal osteoporosis.
    Ettinger B
    Curr Ther Endocrinol Metab; 1994; 5():596-600. PubMed ID: 7704802
    [No Abstract]   [Full Text] [Related]  

  • 13. Does estrogen adequately protect postmenopausal women against osteoporosis: an iconoclastic perspective.
    Orwoll ES; Nelson HD
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1872-4. PubMed ID: 10372678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M
    J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic concepts in the treatment of postmenopausal osteoporosis].
    Leidig-Bruckner G; Ziegler R
    Ther Umsch; 1994 Nov; 51(11):737-47. PubMed ID: 7839332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
    Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal osteoporosis and hormone replacement therapy.
    Gambacciani M; Vacca F
    Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lack of effect of progestogen on bone.
    Lindsay R
    J Reprod Med; 1999 Feb; 44(2 Suppl):215-20. PubMed ID: 11392035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Recent evidence of estrogen therapy for osteoporosis].
    Higuchi T; Mizunuma H
    Clin Calcium; 2008 Aug; 18(8):1141-6. PubMed ID: 18677052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.